Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 09 MAY 2020

Patents And Their Role In A COVID-19 Cure

Smart & Biggar
Explore more from Smart & Biggar

n the current COVID-19 climate, many researchers and pharmaceutical companies are rushing to find both treatment and vaccines. COVID-19 (SARS-CoV-2) is a new type of coronavirus related to the...

CanadaIntellectual Property
Melanie Szweras
Melanie Szweras
Carmela De Luca
Carmela De Luca
Author LinkedIn connections

In the current COVID-19 climate, many researchers and pharmaceutical companies are rushing to find both treatment and vaccines. COVID-19 (SARS-CoV-2) is a new type of coronavirus related to the Severe Acute Respiratory Syndrome (SARS) coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome (MERS) coronavirus (MERS-CoV). According to the BIO SmartBrief article of April 13, 2020, there are over 160 drug and vaccine candidates that are currently being pursued at various stages of development.1 There is a great emphasis on the sharing of innovative technology and know-how as everyone comes together to fight this common enemy. This is evident in the collaborations between various players in the industry and the access being afforded to proprietary resources. Excelra has made their COVID-19 Drug Repurposing Database open access,2 CAS has produced an overview of published scientific information with an emphasis on patents in the CAS content collection with a focus on

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

When AI Meets Copyright: SOCAN v Suno And The Broader AI Copyright Landscape

The Society of Composers, Authors and Music Publishers of Canada has launched a landmark Federal Court claim against AI music platform Suno, alleging systematic copyright infringement on a massive scale. As Canadian courts prepare to address whether AI platforms can infringe existing copyrights and whether AI-generated works merit protection, these cases will establish critical precedents for how generative AI intersects with intellectual property law across all industries.
CanadaIntellectual Property
McMillan LLP
McMillan LLP
Article

Health Canada Updates Policies On Foreign Regulatory Actions, Summary Reporting, Compliance & Enforcement And Requests For New Data

Health Canada issued revised guidance on notifying Health Canada of foreign actions, effective October 1, 2026. The revised guidance clarifies the requirements to notify Health Canada of certain foreign regulatory actions specified in subsection C.01.050(2) of the Food and Drug Regulations in the specified foreign jurisdictions, which involve a serious risk of injury to human health and are relevant to the safety of the drug.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar
Article

Health Canada Obtains Permanent Injunction To Prevent Illegal Sale Of Injectable Peptides By Canlab Research

Health Canada has secured a permanent injunction against Canlab Research, a Quebec-based online retailer, preventing the company from manufacturing, distributing, or selling unauthorized injectable peptides in Canada. This enforcement action follows years of regulatory warnings and provisional court orders aimed at stopping the illegal sale of peptide drugs promoted with unproven health claims for anti-aging, weight loss, and athletic performance.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar